News | June 29, 2022
Glenmark Pharmaceuticals expand its OTC portfolio
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
Safety in these pediatric populations was consistent with the known safety profile across approved adult and pediatric indications1,2
Silo enters into commercial evaluation license agreement for next generation liposomes
It´s the first trial to demonstrate the benefits of dual pathway inhibition
Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials
The capacity addition in Suwa is part of Saint-Gobain Life Sciences ongoing investment plan to globally expand production capacity for its products and services used throughout the bioprocessing industry
Glenmark is the first company in India to market the innovative FDC of Indacaterol
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
Redbiotec has a right to royalties on Eurocine Vaccines´ net sales of an approved HSV-2 vaccine, should such sales arise.
Plans to establish six state of the art TaCa Centre for Surgery in next 2 years in these states
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
